Chinese are good at taking...Exactly. My senti
Post# of 148286
My sentiments exactly along with several additional reactions. 1) Any study of the CCR/L axis that does not mention LL is by definition - deficient. More to come? 2) It is a Chinese study. 3) Chinese interest in the CCR/L axis is not just one more science study of the immune response axis CCR/L, it is potentially an incursion on protected big pharma territory. 4) Chinese interest, not being subject to US big pharma interests might at last, provoke a necessary public and defensive big pharma response to LL than has been the case thus far.